Skip Navigation. Skip Navigation and Go To Content

Sponsored Projects Administration

SPA COVID-19 Updates

GRANT SPONSORS:  COVID-19 NOTICES AND UPDATES

SPA is actively receiving and seeking out current updates from our grant sponsors regarding grant activities affected by the COVID-19 pandemic. The information below will be updated throughout the day as new information is received.

Contact your SPA grant specialist, Carmen Martinez, or Kathleen Kreider with any questions you may have.

SPA staff members are working remotely with a skeleton crew on campus.

Office of Management and Budget:  has authorized federal granting agencies the flexibility in several administrative areas of due to loss of operational capacity and increased costs due to COVID-19. https://www.whitehouse.gov/wp-content/uploads/2020/03/M-20-17.pdf

COGR Matrix:  Federal Agency Administrative flexibilities 

https://www.cogr.edu/

Each federal agency will release it’s own implementation plan.

NIH:  YouTube message from Mike Lauer, M.D. regarding administrative grant flexibilities

https://youtu.be/jLmBi5wvifk

NIH Website updates and FAQs:  https://grants.nih.gov/grants/natural_disasters/corona-virus.htm

NIH Proposal Submission:  https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-082.html

NIH Award Management/Reporting:  https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-086.html

CPRIT:  Covid-19 webpage for grantees and applicants.  https://www.cprit.texas.gov/about-us/novel-coronavirus-covid-19

DHHS-Administration for Children and Families (ACF):  Released grant flexibilities statement.  Read here

Howard Hughes Medical Institute suspends Medically Trained Scientists Program  https://www.hhmi.org/news/hhmi-opens-new-program-for-medically-trained-scientists

Methodist Healthcare Ministries of South Texas:  Read Here

NSF:  https://www.nsf.gov/bfa/dias/policy/covid19/covid19faqs_proposerandawardee.pdf

SAMHSAhttps://www.samhsa.gov/coronavirus/discretionary-grant-recipients

TDSHS: Options for 90-day Administrative Relief: Read Here

TWC Governor’s Summer Merit Program: Cancelled for this year: Read Here

USAMRAA:  https://ebrap.org/eBRAP/public/COVID-19_FAQs_USAMRAA_16_MARCH_2020.html

Center for Clinical And Translational Sciences (CCTS) at UTHealth:  Letter from David McPherson, M.D. regarding ongoing support of clinical trials. Read Here.

Subrecipients/Subawards:  Sponsored Projects Officers around the country have confirmed that they are operating remotely and will continue to issue subawards as scheduled.

Proposal Deadline Extensions and Other Opportunities

Harrington Discovery Institute:  Deadline extended for Scholar Innovator Award (MD required, all disease areas, $100,000 - $700,000)   and the Scholar Award (Partner with Alzheimer’s Drug Discovery Foundation,  PHD or MD, Alzheimer’s and dementias, other drug development programs, up to $600,000) https://www.uhhospitals.org/harrington-discovery-institute/funding-and-programs/alzheimers-drug-discovery-foundation-harrington-program

PCORI Phased Large Awards for Comparative Effectiveness:  RFA will open 6/9/20,  LOI due 9/29/20,  application due 1/12/21.   $2 million Feasibility phase and $20 million full-scale study phase  for high-quality comparative effectiveness research (CER) projects that will examine a critical patient-centered research question that is also relevant to decision makers and other stakeholders. For this PFA, investigators should propose an individual-level or cluster randomized controlled trial of significant scale and scope, requiring funding in excess of $10 million in direct costs. The proposed trials should address important decisional dilemmas that require important new evidence about the comparative effectiveness of available interventions. Proposed studies should compare interventions that already have established evidence of efficacy or are in widespread use. Clinical interventions (such as medications, diagnostic tests, or procedures) and delivery system interventions are appropriate for study.  https://www.pcori.org/funding-opportunities/announcement/phased-large-awards-comparative-effectiveness-research-cycle-3-2020?utm_source=placer&utm_medium=email&utm_campaign=030420

Requests for Proposals to Address COVID-19

Cornerstone – List of federal funding opportunities for Covid-19

    4/9/20  -  page 7 begins description of each opportunity by fed agency.  Read Here

    4/10/20 – New opportunities.  Read Here

NOT-AI-20-034

Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome

National Institute of Allergy and Infectious Diseases (NIAID)

NOT-AI-20-040

Notice of Early Expiration of “Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019

National Institute of Allergy and Infectious Diseases (NIAID)

NOT-GM-20-025

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19)

National Institute of General Medical Sciences (NIGMS)

NOT-AI-20-030

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of General Medical Sciences (NIGMS)

NOT-HL-20-757

Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)

National Heart, Lung, and Blood Institute (NHLBI)

NOT-DA-20-047

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus

National Institute on Drug Abuse (NIDA)

NIH:  CTSA Notice of special Interest (2 RFAs for a supplement and limited competition under our UL1 award). If you wish to submit a proposal in response to one of these RFA’s, please contact David McPherson, MD, PI for the UTHealth CTSA.

https://grants.nih.gov/grants/guide/notice-files/NOT-TR-20-011.html